Literature DB >> 1424107

Parathyroid hormone-related protein: structure, function, and measurement.

W J Burtis1.   

Abstract

Parathyroid hormone-related protein (PTHRP) is a 139- to 173-amino-acid protein with N-terminal homology to parathyroid hormone (PTH). Initially isolated from tumors from patients with humoral hypercalcemia of malignancy, PTHRP appears to be of far more widespread physiological importance. Its complex gene is expressed in a surprising diversity of tissues. The primary amino acid sequences of both the PTH-like and non-PTH-like regions of the protein are highly conserved across species. In addition to classical and nonclassical PTH-like activities of the N-terminal region, other biological functions have been ascribed, including augmentation of calcium transport by midregion PTHRP and potent inhibition of bone resorption by a C-terminal peptide. There is emerging evidence that the protein undergoes extensive processing, including glycosylation and defined proteolytic cleavages. Several region-specific immunoassays are now capable of measuring circulating concentrations of PTHRP in patients with humoral hypercalcemia of malignancy. Molar concentrations of different regions may differ by more than an order of magnitude, reflecting diversity in processing and (or) metabolism. By analyzing the results of these assays, taking into account the specificities of known endoproteases, one can hypothesize about some of the endoproteolytic cleavages that occur in PTHRP metabolism. Clinically, selected PTHRP assays can be very helpful in diagnosing PTHRP-mediated hypercalcemia, but are not yet sufficiently sensitive to accurately measure normal concentrations of the protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424107

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

Review 1.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma.

Authors:  Makoto Tsuchimochi; Ayako Kameta; Mikiko Sue; Masataka Katagiri
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

3.  Alteration of secretion of parathyroid hormone-related peptide and expression of its mRNA in a human hepatoma cell line (HEP G2) treated with agents that affect cell growth.

Authors:  H Li; P K Seitz; P Selvanayagam; S Rajaraman; C W Cooper
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

4.  Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.

Authors:  Giovanni Almadori; Antonella Coli; Eugenio De Corso; Dario Antonio Mele; Stefano Settimi; Giovanni Di Cintio; Francesca Brigato; Domenico Scannone; Libero Lauriola; Franco Oreste Ranelletti
Journal:  BMC Cancer       Date:  2022-06-27       Impact factor: 4.638

5.  Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.

Authors:  A C Hutchesson; N J Bundred; W A Ratcliffe
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

6.  PTHrP is a novel mediator for TGF-β-induced apoptosis.

Authors:  Yanna Cao; Weili Zhang; Xuxia Gao; Guohua Zhang; Miriam Falzon; Courtney M Townsend; Mark R Hellmich; Tien C Ko
Journal:  Regul Pept       Date:  2013-03-13

7.  Parathyroid hormone-related protein in healthy pregnant women.

Authors:  S Bertelloni; G I Baroncelli; A Pelletti; R Battini; G Saggese
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

8.  Parathyroid hormone-like protein is a secretory product of atrial myocytes.

Authors:  L J Deftos; D W Burton; D W Brandt
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Circulating concentrations of interleukin-6 in cancer patients and their pathogenic role in tumor-induced hypercalcemia.

Authors:  B Vanderschueren; J C Dumon; V Oleffe; C Heymans; J Gérain; J J Body
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

10.  PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis.

Authors:  Isabella W Y Mak; Robert W Cowan; Robert E Turcotte; Gurmit Singh; Michelle Ghert
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.